MACROGENICS INC
Biopharma firm developing innovative antibody-based therapeutics for cancer treatment.
MGNX | NDAQ
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- United States of America
- Address:
- 9704 MEDICAL CENTER DRIVE, 20850 Rockville
- Website:
- https://www.macrogenics.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
MacroGenics, Inc. is a biopharmaceutical company focused on discovering, developing, manufacturing, and commercializing innovative antibody-based therapeutics for the treatment of cancer. The company leverages its fully-integrated development capabilities, including GMP manufacturing, to create breakthrough biologics for patients with unmet medical needs. Its broad pipeline of investigational product candidates includes monoclonal antibodies, antibody-drug conjugates (ADCs), and multi-specific antibodies engineered with proprietary technology platforms such as DART® and TRIDENT®. MacroGenics is dedicated to creating life-changing medicines by utilizing its next-generation antibody technologies to address complex diseases, primarily in the field of oncology.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all MACROGENICS INC filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for MACROGENICS INC
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for MACROGENICS INC via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
